Compare companies
ASKA Pharmaceutical Holdings Co.,Ltd. | Chugai Pharmaceutical Co., Ltd. | Takeda Pharmaceutical Company Limited | ||||
---|---|---|---|---|---|---|
Capitalization | ||||||
Price | 2325 | 7036 | 4545 | |||
Price priv. | ||||||
Number of shares, million | 28.31 | 1645.5 | 1580.34 | |||
Capitalization, billion | 39.94 | 6930 | 6830 | |||
EBITDA, billion | 12.57 | 447.41 | 874.6 | |||
EV, billion | 58.88 | 8356.56 | 11284.15 | |||
Profit and loss report | ||||||
Net profit, billion | 7.55 | 325.47 | 144.07 | |||
Revenue, billion | 62.84 | 1111.37 | 4263.76 | |||
EPS | 266.49 | 197.8 | 91.16 | |||
Balance | ||||||
Assets, billion | 90.75 | 1932.55 | 15108.79 | |||
Debt, billion | 9.49 | 13.46 | 4843.75 | |||
Balance cost, billion | 61.93 | 1625.58 | 7273.26 | |||
Cash, billion | 13.74 | 458.67 | 457.8 | |||
Coefficients | ||||||
Dividend yield, % | 2.57 | 2.06 | 6.79 | |||
Dividend | 45 | 98 | 192 | |||
Dividend yield priv., % | 0 | 0 | 0 | |||
Dividend priv. | 0 | 0 | 0 | |||
Dividends/profit, % | 10.5 | 40.43 | 199.34 | |||
P/S | 1 | 7.92 | 1.62 | |||
P/BV | 1.02 | 5.41 | 0.9483 | |||
P/E | 8.37 | 27.04 | 47.88 | |||
Ev/Ebitda | 4.69 | 18.68 | 12.9 | |||
Debt/Ebitda | 0.7548 | 0.0301 | 5.54 | |||
Efficiency | ||||||
ROE | 12.96 | 20.02 | 2.11 | |||
ROA | 8.48 | 16.84 | 0.9913 | |||
ROIC | 7.49 | 0 | 5.63 | |||
Ebitda margin | 20 | 40.26 | 20.51 | |||
Net margin | 12.01 | 29.29 | 3.38 | |||
Momentum | ||||||
1 week, price changes | +5.68 % | +5.27 % | -0.0881 % | |||
1 month, price changes | +20.97 % | -9.85 % | +5.89 % | |||
3 months, price changes | +11.24 % | +2.09 % | +9.65 % | |||
6 months, price changes | +8.39 % | -3.38 % | +8.91 % | |||
1 year, price changes | +10.5 % | +19.64 % | +3.33 % | |||
3 years, price changes | +24.87 % | |||||
5 years, price changes | ||||||
10 years, price changes |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription